Ohcanbohtosat - Carol Aghajanian
- Čájehuvvo 1 - 20 / 113
- Sirdás čuovvovaš siidui
-
1
Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer Dahkki Carol Aghajanian, Barbara A. Goff, Lawrence R. Nycum, Yan V. Wang, Amreen Husain, Stephanie V. Blank
Almmustuhtton 2015Artigo -
2
-
3
Ovarian clear cell carcinoma, outcomes by stage: The MSK experience Dahkki Catherine A. Shu, Qin Zhou, Anjali R. Jotwani, Alexia Iasonos, Mario M. Leitão, Jason Konner, Carol Aghajanian
Almmustuhtton 2015Artigo -
4
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models Dahkki Hannah Wise, Gopa Iyer, Kathleen N. Moore, Sarah M. Temkin, Sarah Gordon, Carol Aghajanian, Rachel N. Grisham
Almmustuhtton 2019Artigo -
5
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I–IV uterine carcinosarcoma Dahkki Vicky Makker, Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Carol Aghajanian, Qin Zhou, Alexia Iasonos, Martee L. Hensley
Almmustuhtton 2008Artigo -
6
-
7
-
8
-
9
Risk factors for recurrence of ovarian borderline tumors Dahkki Karin Shih, Qin Zhou, Jae Huh, Jessica Morgan, Alexia Iasonos, Carol Aghajanian, D.S. Chi, R.R. Barakat, Nadeem R. Abu‐Rustum
Almmustuhtton 2010Artigo -
10
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial c... Dahkki Vicky Makker, Virginia L. Filiaci, Lee-may Chen, Christopher J. Darus, James E. Kendrick, Gregory P. Sutton, Katherine Moxley, Carol Aghajanian
Almmustuhtton 2015Artigo -
11
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian,... Dahkki Carol Aghajanian, Stephanie V. Blank, Barbara A. Goff, Patricia L. Judson, Michael Teneriello, Amreen Husain, Mika A. Sovak, Jing Yi, Lawrence R. Nycum
Almmustuhtton 2012Artigo -
12
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer... Dahkki Bradley J. Monk, James Kauderer, Katherine Moxley, Albert J. Bonebrake, Summer Dewdney, Angeles Alvarez Secord, Frederick R. Ueland, Carolyn M. Johnston, Carol Aghajanian
Almmustuhtton 2018Artigo -
13
Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous end... Dahkki Jennifer J. Mueller, Silvana Pedra Nobre, Kenya Braxton, Kaled M. Alektiar, Mario M. Leitão, Carol Aghajanian, Lora H. Ellenson, Nadeem R. Abu‐Rustum
Almmustuhtton 2020Artigo -
14
-
15
Cancer-Related Infertility in Survivorship Dahkki Jeanne Carter, S. Dennis, Carol L. Brown, Nadeem R. Abu‐Rustum, Yukio Sonoda, Carol Aghajanian, Douglas A. Levine, Raymond E. Baser, Leigh Raviv, Richard R. Barakat
Almmustuhtton 2010Revisão -
16
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer Dahkki Sushmita Gordhandas, Beryl Manning‐Geist, Christina Henson, Gopa Iyer, Ginger J. Gardner, Yukio Sonoda, Kathleen N. Moore, Carol Aghajanian, M. Herman Chui, Rachel N. Grisham
Almmustuhtton 2022Artigo -
17
Development of a risk stratification system to guide treatment for female germ cell tumors Dahkki Jane Meisel, Kaitlin M. Woo, Nora Sudarsan, Jana Eng, Sujata Patil, Erin Jacobsen, Rajmohan Murali, Ginger J. Gardner, George J. Bosl, Carol Aghajanian, Darren R. Feldman
Almmustuhtton 2015Artigo -
18
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma Dahkki Aung Naing, Carol Aghajanian, Éric Raymond, David Olmos, Gary G. Schwartz, Elisabeth Oelmann, Lynda Grinsted, Wendy Burke, Rosie Taylor, Stan B. Kaye, Razelle Kurzrock, Udai Banerji
Almmustuhtton 2012Artigo -
19
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity Dahkki David Gallagher, Jason Konner, K.M. Bell-McGuinn, Jasmine Bhatia, Paul Sabbatini, Carol Aghajanian, Kenneth Offit, R.R. Barakat, David R. Spriggs, Noah D. Kauff
Almmustuhtton 2010Artigo -
20
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Dahkki Mario M. Leitão, Robert A. Soslow, Daisuke Nonaka, Adam B. Olshen, Carol Aghajanian, Paul Sabbatini, Jakob Dupont, Martee L. Hensley, Yukio Sonoda, Richard R. Barakat, Sibyl Anderson
Almmustuhtton 2004Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Cancer
Oncology
Ovarian cancer
Biology
Chemotherapy
Gene
Genetics
Surgery
Gastroenterology
Endometrial cancer
Cancer research
Confidence interval
Hazard ratio
Pathology
Poly ADP ribose polymerase
Polymerase
Bevacizumab
Paleontology
Stage (stratigraphy)
Adverse effect
Biochemistry
Immunotherapy
Breast cancer
Clinical endpoint
Cisplatin
Gynecologic oncology
Alternative medicine
Carboplatin